To include your compound in the COVID-19 Resource Center, submit it here.

G17DT: Phase III

In a double-blind, European Phase III trial in 154 patients,

Read the full 102 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE